ANDA 83858, held by Marshall Pharma. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 83858 (Sodium Butabarbital), held by Marshall Pharma, was first approved by FDA on Mar 14, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 14, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Butabarbital32.4MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters